These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2735662)

  • 1. Relative efficacy of heparin and related glycosaminoglycans as antithrombotic drugs.
    Thomas DP; Merton RE; Barrowcliffe TW
    Ann N Y Acad Sci; 1989; 556():313-22. PubMed ID: 2735662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of heparin oligosaccharides with high affinity for antithrombin III in experimental venous thrombosis.
    Thomas DP; Merton RE; Barrowcliffe TW; Thunberg L; Lindahl U
    Thromb Haemost; 1982 Jun; 47(3):244-8. PubMed ID: 7112499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental studies on the relative efficacy of dermatan sulphate and heparin as antithrombotic agents.
    Merton RE; Thomas DP
    Thromb Haemost; 1987 Oct; 58(3):839-42. PubMed ID: 3433248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dermatan sulfate and heparin on inhibition of thrombus growth in vivo.
    Van Ryn-McKenna J; Ofosu FA; Gray E; Hirsh J; Buchanan MR
    Ann N Y Acad Sci; 1989; 556():304-12. PubMed ID: 2735661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relative antithrombotic effectiveness of heparin, a low molecular weight heparin, and a pentasaccharide fragment in an animal model.
    Thomas DP; Merton RE; Gray E; Barrowcliffe TW
    Thromb Haemost; 1989 Apr; 61(2):204-7. PubMed ID: 2546282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low affinity heparin is an antithrombotic agent.
    Gray E; Cesmeli S; Lormeau JC; Davies AB; Lane DA
    Thromb Haemost; 1994 Feb; 71(2):203-7. PubMed ID: 8191399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The haemorrhagic and antithrombotic effects of dermatan sulphate.
    Fernandez F; Van Ryn J; Ofosu FA; Hirsh J; Buchanan MR
    Br J Haematol; 1986 Oct; 64(2):309-17. PubMed ID: 3778825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relative importance of thrombin inhibition and factor Xa inhibition to the antithrombotic effects of heparin.
    Buchanan MR; Boneu B; Ofosu F; Hirsh J
    Blood; 1985 Jan; 65(1):198-201. PubMed ID: 3965047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic activity of a synthetic heparin pentasaccharide in a rabbit stasis thrombosis model using different thrombogenic challenges.
    Walenga JM; Petitou M; Lormeau JC; Samama M; Fareed J; Choay J
    Thromb Res; 1987 Apr; 46(2):187-98. PubMed ID: 3603420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of heparin, dermatan sulfate and of their association on the inhibition of venous thrombosis growth in the rabbit.
    Carrie D; Caranobe C; Gabaig AM; Larroche M; Boneu B
    Thromb Haemost; 1992 Dec; 68(6):637-41. PubMed ID: 1287877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo activity of a new heparinoid.
    Ockelford PA; Carter CJ; Hirsh J
    Pathology; 1985 Jan; 17(1):78-81. PubMed ID: 4000717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic effects of heparin oligosaccharides.
    Mattsson C; Palm M; Söderberg K; Holmer E
    Ann N Y Acad Sci; 1989; 556():323-32. PubMed ID: 2735663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pentasaccharide and Orgaran arrest, whereas heparin delays thrombus formation in a rat arteriovenous shunt.
    Vogel GM; van Amsterdam RG; Kop WJ; Meuleman DG
    Thromb Haemost; 1993 Jan; 69(1):29-34. PubMed ID: 8446935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic properties of dermatan sulphate in a rat venous thrombosis model.
    Maggi A; Abbadini M; Pagella PG; Borowska A; Pangrazzi J; Donati MB
    Haemostasis; 1987; 17(6):329-35. PubMed ID: 3428718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standard heparin enhances the antithrombotic activity of dermatan sulfate in the rabbit but CY 216 does not.
    Cadroy Y; Dol F; Caranobe C; Petitou M; Lormeau JC; Sié P; Choay J; Boneu B
    Thromb Haemost; 1988 Apr; 59(2):295-8. PubMed ID: 2838927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic activity of dermatan sulphates, heparins and their combination in an animal model of arterial thrombosis.
    Iacoviello L; D'Adamo MC; Pawlak K; Polishchuck R; Wollny T; Buczko W; Donati MB
    Thromb Haemost; 1996 Dec; 76(6):1102-7. PubMed ID: 8972038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orgaran (Org 10172): its pharmacological profile in experimental models.
    Meuleman DG
    Haemostasis; 1992; 22(2):58-65. PubMed ID: 1379965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibition of the generation of thrombin and the antithrombotic effect of a pentasaccharide with sole anti-factor Xa activity.
    Walenga JM; Bara L; Petitou M; Samama M; Fareed J; Choay J
    Thromb Res; 1988 Jul; 51(1):23-33. PubMed ID: 3166242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of the antithrombotic action of dermatan sulphate by small amounts of heparin.
    Thomas DP; Gray E; Merton RE
    Thromb Haemost; 1990 Oct; 64(2):290-3. PubMed ID: 2270536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different antithrombotic mechanisms among glycosaminoglycans revealed with a new fucosylated chondroitin sulfate from an echinoderm.
    Pacheco RG; Vicente CP; Zancan P; Mourão PA
    Blood Coagul Fibrinolysis; 2000 Sep; 11(6):563-73. PubMed ID: 10997797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.